Zydus Wellness Q1 Review - Good Quarter With Improving Margin Trajectory: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Zydus Wellness Ltd.'s Q1 FY22 was decent with broad-based growth across brands. Expansion in e-commerce and improving international business is positive.
We continue to believe that the acquisition of Heinz India business is transformational for Zydus Wellness, given the increased consumer focus on health and wellness – likely accelerated consumer adoption of more than 70% of the portfolio (Sugar Free, Glucon-D, Nutralite and Complan).
We especially like the new product development strategy (contributes ~3.5% versus ~1.5 earlier) aimed to address some key challenges – SugarLite to address the taste penalty, Sugar Free Green is a natural product, Complan Nutrigro to regain lost medical connect of the brand.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.